Marshall Wace North America’s ResMed RMD Stock Holding History

Marshall Wace North America’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$2.27M	Buy	+8,603	New	+$2.35M	0.01%	698
2021 Q2	–	Sell	-301,038	Closed	-$58.4M	–	1723
2021 Q1	$58.4M	Buy	301,038 +187,276	+165%	+$37.6M	0.24%	94
2020 Q4	$24.2M	Sell	113,762 -103,221	-48%	-$20.6M	0.11%	213
2020 Q3	$37.2M	Buy	+216,983	New	+$40.1M	0.24%	109
2020 Q2	–	Sell	-170,234	Closed	-$25.1M	–	1426
2020 Q1	$25.1M	Buy	+170,234	New	+$27.1M	0.19%	137
2019 Q3	–	Sell	-7,534	Closed	-$919K	–	1512
2019 Q2	$919K	Buy	7,534 +4,167	+124%	+$462K	0.01%	777
2019 Q1	$350K	Sell	3,367 -24,446	-88%	-$2.52M	﹤0.01%	871
2018 Q4	$3.17M	Buy	+27,813	New	+$2.98M	0.03%	337
2018 Q3	–	Sell	-15,420	Closed	-$1.6M	–	1301
2018 Q2	$1.6M	Sell	15,420 -25,573	-62%	-$2.59M	0.01%	822
2018 Q1	$4.04M	Buy	40,993 +29,154	+246%	+$2.76M	0.02%	616
2017 Q4	$1M	Buy	+11,839	New	+$978K	0.01%	990
2017 Q2	–	Sell	-3,738	Closed	-$269K	–	1438
2017 Q1	$269K	Buy	+3,738	New	+$258K	﹤0.01%	880
2013 Q4	$22.3M	Buy	+473,714	New	+$24M	0.47%	60

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Marshall Wace North America's RMD Position: Q3 2021 in Review

Marshall Wace North America opened a new position in ResMed (RMD) in Q3 2021: 8,603 shares worth $2.27M. The stake represents 0.01% of the portfolio and ranks #698 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in RMD as recently as Q1 2021.

Marshall Wace North America first reported a position in RMD in Q4 2013 and has held it in 13 quarters since. The position peaked at $58.4M in Q1 2021. 687 funds tracked by Wall St. Rank hold RMD as of Q3 2021.

Marshall Wace North America held 8,603 shares of ResMed worth $2.27M as of Q3 2021.
ResMed was a new Marshall Wace North America position in Q3 2021.
ResMed made up 0.01% of Marshall Wace North America's portfolio in Q3 2021, its #698 holding.
Marshall Wace North America first reported a position in ResMed in Q4 2013 and has held it in 13 quarters since.
Marshall Wace North America's ResMed position peaked at $58.4M in Q1 2021.
687 funds tracked by Wall St. Rank held ResMed as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.